Search Results for "Abbott Dartford Murex Biotech Ltd"

16:02 EDT 30th March 2015 | BioPortfolio

Matching Channels

Abbott

The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

Matching News

Abbott Acquires Veropharm for $305M

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.Abbott has had a presence in Russia for nearly 40 years and, in line with its long-term commit...

Abbott Announces Increase in Quarterly Dividend

ABBOTT PARK, Ill., Dec. 12, 2014 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to $0.24 per share from $0.22 per share....

Abbott to Present at Credit Suisse 2014 Healthcare Conference

ABBOTT PARK, Ill., Nov. 4, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Credit Suisse 2014 Healthcare Conference on Tuesday, Nov. 11, 2014. Thomas C. Freyman, executive vice preside...

Abbott to Present at Leerink Global Healthcare Conference

ABBOTT PARK, Ill., Feb. 4, 2015 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Leerink Global Healthcare Conference on Thursday, Feb. 12, 2015. Thomas C. Freyman, executive vice pres...

Abbott Declares 365th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Feb. 20, 2015 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 24 cents per share. This marks the 365th consecut...

Mylan and Abbott: it's still on

"We remain on track to divest our developed markets business in Mylan in the first quarter of next year," said Abbott CEO Miles White this week when presenting Abbott's third quarter results. Also, Ab...

Conflict in the NBA with ESPN’s Henry Abbott on SCI TV

Portland, OR (PRWEB) November 30, 2014 In this November episode of SCI TV , Joshua Gordon and Ken Pendleton explore issues in the NBA with Senior NBA writer and founder of the TrueHoop NBA blog,...

Abbott announces acquisition of Topera for $250 million

Abbott has entered into an acquisition agreement to purchase Topera. Topera is a private, venture-backed medical device company focused on developing innovative electrophysiology technologies to impro...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement